Hudson Research Center, The

HiberCell is the first company exclusively focused on tumor dormancy detection and therapeutics. The company is developing first-in-class therapeutics that target dormant disseminated tumor cells (DTCs) from solid and liquid cancers, with the ultimate goal of preventing cancer relapse and metastasis. *

	Start	2019-02-07 existent
	Industry	business park management / science park management
	Industry 2	LIFE SCIENCES

	Region	New York, NY
	Country	United States (USA)
	Street	619 West 54th Street
	City	10019 New York, NY
		Address record changed: 2019-02-13

Basic data	Employees	n. a.

		* Document for »About Section«: HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY.

		Record changed: 2019-02-13

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]